Trajan Wealth LLC Takes $19.35 Million Position in The Cooper Companies, Inc. $COO

Trajan Wealth LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 269,803 shares of the medical device company’s stock, valued at approximately $19,348,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Heartland Advisors Inc. bought a new stake in Cooper Companies during the 4th quarter valued at approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Cooper Companies by 6.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock worth $34,224,000 after buying an additional 23,896 shares during the period. Swedbank AB increased its position in Cooper Companies by 18.8% in the 4th quarter. Swedbank AB now owns 1,074,029 shares of the medical device company’s stock worth $88,027,000 after buying an additional 170,000 shares during the period. Capital International Inc. CA lifted its holdings in shares of Cooper Companies by 22.9% during the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock worth $9,688,000 after buying an additional 22,054 shares during the last quarter. Finally, Tocqueville Asset Management L.P. acquired a new position in shares of Cooper Companies during the second quarter worth approximately $1,502,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NASDAQ COO opened at $75.80 on Tuesday. The stock has a market cap of $14.78 billion, a P/E ratio of 64.24, a PEG ratio of 1.99 and a beta of 0.83. The company’s 50-day simple moving average is $72.09 and its 200 day simple moving average is $71.07. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of a number of research reports. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Finally, UBS Group started coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.